Graduate Medical Education (GME): Pediatric Hematology-Oncology

Fellowship Program Directors:
Don Small, MD, PhD
Stacy Cooper, MD
Nirali N. Shah, MD
Clifford Takemoto, MD

Overview
The fellowship is designed to provide clinical and research exposure that allows for the development of subspecialist academicians adept in laboratory and/or clinical research, coupled with superior patient management skills. Training in Pediatric Oncology is under the direction of Drs. Don Small and Stacy Cooper at Johns Hopkins Hospital (JHH). Training in Pediatric Hematology is under the direction of Dr. Clifford Takemoto, Co-Director of Fellowship Training at JHH. Training in Pediatric Oncology at the National Cancer Institute (NCI), National Institutes of Health (NIH) is under the direction of Dr. Nirali Shah, Co-Director of Fellowship Training. Six fellows per year are selected via the National Residency Matching Program (NRMP). The first year of the fellowship is largely clinical with inpatient and outpatient exposure at JHU and the NIH. The second and third years are focused research years allowing for training in laboratory and/or clinical research.

Program Structure
The first year fellowship will include:

  • JHU Hematology Inpatient Service
  • JHU Hematology Outpatient Service
  • JHU Hematology Laboratory Training
  • JHU Oncology Service (Green and Blue Team)
  • NIH Inpatient Oncology
  • NIH Outpatient Oncology
  • Continuity Clinic (weekly during selected rotations)

The second and third years of fellowship are designed to be focused research years. Among the many advantages of the combined JHU/NCI training program is the wide range of research opportunities available to each fellow. Laboratory and clinical research at both institutions are unparalleled and the combined program allows the fellow to choose among a vast number of research options. To ensure maximum productivity, clinical responsibilities are limited and focused on continuity of care for patients encountered by the fellow during the first year of training. The remainder of this protected time is spent pursuing a research initiative tailored to the specific interests of the fellow. Decisions regarding the appropriate locale for research training are made in concert with faculty advisors and fellowship directors. Many fellows focus on basic science research, either in the laboratories of faculty members in Pediatric Hematology/Oncology at either institution or in other appropriate laboratory settings. Fellows are free to choose among the many laboratories at JHU and throughout the intramural NIH community. Selected fellows who have chosen to focus on clinical research may apply to the clinical research program offered via Duke University as a joint program with the NIH leading to a Master's Degree in Clinical Research. Alternatively, fellows may have the option to enroll at the JHU Bloomberg School of Public Health, where formal training and a clinical research experience is provided in the expectation of fellows obtaining a PhD in Clinical Investigation. Fellows may also apply for advanced studies in clinical research through an NIH/POB program providing up to three years of additional research training following the completion of the initial three years of fellowship training.

Additional Information
For more information, please visit the Pediatric Hematology-Oncology Fellowship Program webpage.

Application Procedure
Applicants who wish to apply to the combined fellowships will need to apply through ERAS. Qualifications for Acceptance:

  • Applicants whose supporting documentation and letters of reference are exemplary will be invited to interview. No application will be accepted without an interview
  • Accepted applicants will successfully complete training in an ACGME certified pediatric residency or med/peds program
  • Applicants trained in foreign countries must have an ECFMG certificate if they have not subsequently trained in an ACGME certified pediatric program
  • An applicant who is not a citizen of the United States or a permanent resident must be eligible for an appropriate visa (i.e., J1 or HB).

NOTE: PDF documents require the free Adobe Reader.

This page last updated on 11/04/2022

You are now leaving the NIH Clinical Center website.

This external link is provided for your convenience to offer additional information. The NIH Clinical Center is not responsible for the availability, content or accuracy of this external site.

The NIH Clinical Center does not endorse, authorize or guarantee the sponsors, information, products or services described or offered at this external site. You will be subject to the destination site’s privacy policy if you follow this link.

More information about the NIH Clinical Center Privacy and Disclaimer policy is available at https://www.cc.nih.gov/disclaimers.html